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Methods: 1st step: The selected peptide precursor was loaded onto
the microfluidic chip activated with 2 ml of water and 2 ml of EtOH
and then flushed with 0.1 M MES mobile phase at pH 5.5. As a model
peptide we chose DOTA-TOC that was injected in a 500 μl volume
(12.5 μg) and deposited on the sorbent matrix (C18t, 20 mg in a vol-
ume of 100 μl).
2nd step: The microfluidic chip was heated up to 95 °C and a chosen
radiometal was injected into the system (64Cu, 300 MBq, 1 MBq/μl in
0.1 MES buffer). The free radiometal was eluted to waste, while the
chelated radiometal remained on the chip.
3rd step: The radiolabelled product was eluted from the system into
the organic phase (injection of 100 μl of EtOH).
Results: More than 90 % of the 64Cu activity was absorbed on
the chip. The radiolabelled product was then eluted with 100 μl
of EtOH in amount of 180 MBq, i.e. in the overall yield of 60 %
in ca 25 minutes. Radiochemical purity determined via HPLC was
found to be > 98 %.
Conclusion: We tested a newly designed microfluidic chip system
suitable for radiometal labellings. It was demonstrated on a particular
example of DOTA-TOC and 64Cu that the system allows for rapid
radiolabelling in three simple steps providing high radiochemical
purity product. The chip may be easily operated in GMP-compliant
mode and modified for various couples radiometal-precursor.
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Aim: The aim of this system is to simultaneously improve sensitiv-
ity and resolution with a major step compared to current state-
of-the art PET while maintaining a reasonable cost for the total
system. The first aim of this study is to show the potential of
high resolution monolithic LYSO scintillator with SiPM readout for
a compact Total Body (TB) PET design with only 3-4 times the
detector material of a current PET-CT scanner. The second aim of
this study is the design of a long axial TB-PET system and the
determination of its sensitivity gains for different types of objects.
The transverse diameter of the system is fixed at 65 cm (which
fits nearly all patients) as we expect that the whole bore can be
reconstructed by making use of the Depth-of-interaction capabil-
ities of the monolithic detector.
Methods: This system is characterised with regards to point and line
sensitivity for typical detector settings in current clinical PET systems.
In this study the effects of changing the axial length of the scanner
are studied in detail. Finally two options for imaging long objects
(above 1 m) with the same compact system are described.
Results: The system results in excellent spatial resolution at the sys-
tem level. The sensitivity gains for point sources and small objects
(brain type) are limited and are comparable to the increase in cost of
the system. For longer objects (1-2m) the gains go up to a factor 15-
20 x. Scanners in the range of 70 cm-1m20 match well with the typ-
ical region of interest for PET imaging and have an optimal sensitivity
gain.
Conclusion: PET20.0 combines high and uniform spatial resolution at
the system with a major increase in sensitivity (close to a factor 20)
for total body imaging. This is accomplished by increasing the de-
tector material by a factor 3-4.
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Aim: Digital photon counting serves to improve both visual and
quantitative performance of PET/CT through advances in system sen-
sitivity, count statistics and time of flight timing resolution. Fitting
this data to a normalization curve such as with EARL requires a
reconstruction protocol secondary to the default high definition
protocol. We validated a vendor suggested EARL-compliant protocol
for clinical data sets acquired with digital photon counting PET via
intra-individual comparison to images acquired on a conventional
system.
Methods: 26 patients underwent PET/CT imaging on a conventional
system (Philips Gemini TF 64, cPET) approximately 75 minutes
post-injection of 480 MBq 18F-FDG and 55 minutes on a pre-
commercial release digital photon counting PET/CT system (Philips
Vereos, DPC dPET). Listmode data were reconstructed with default
settings: cPET – 4mm isometric voxel, 3 iterations, 33 subsets; DPC
dPET – 2mm isometric voxel, 3 iterations, 11 subsets, point spread
function correction and 4.1 mm Gaussian filter applied. DPC dPET
data were further reconstructed with an EARL-compliant protocol –
4mm isometric voxel, 3 iterations 13 subsets, 5mm Gaussian filter
which was previously validated with phantom data (1). Regions of
interest (ROIs) were placed over target lesions and in a variety of
background tissues for quantitative comparison.
Results: The average SUVmax of target lesions for default DPC dPET
reconstructions was 9.74. The cPET data presented a substantially
lower average SUVmax at 6.47, as anticipated due to lower recovery
coefficients. The EARL dPET reconstruction revealed quantitative
values comparable to cPET with an average SUVmax of 6.49. The de-
crease was due to an increase in partial volume effects by use of a
smaller reconstruction matrix/larger voxel size as well as the smooth-
ing introduced by the use of a Gaussian filter alone. In background
tissues, the SUVmean varied by less than 5% among all reconstruc-
tion settings.
Conclusion: The EARL-compliant reconstruction of DPC dPET clinical
cases as applied to intra-individual comparison data lead to quantita-
tive results which match conventional EARL PET/CT values. It was
demonstrated and validated that while DPC dPET imaging has sub-
stantially improved recovery coefficients, secondary reconstructions
can be performed to enable comparable quantification with conven-
tional PET systems and existing databases or inclusion in clinical trials.
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